{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:33:22Z","timestamp":1787722402156,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17305-6","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T17:44:15Z","timestamp":1756143855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Ebrahim","family":"Shafiei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaeil","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Mahmoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh","family":"Hajian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sanjideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokrollah","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Smoliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pema","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Netticadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"17305_CR1","unstructured":"WHO launches the World Health Statistics 2012. Euro Surveill. 17 (20) (2012)."},{"issue":"6","key":"17305_CR2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1161\/HYP.0b013e318293645f","volume":"61","author":"RD Brook","year":"2013","unstructured":"Brook, R. D. et al. Beyond medications and diet: alternative approaches to Lowering blood pressure: a scientific statement from the American heart association. Hypertension 61 (6), 1360\u20131383 (2013).","journal-title":"Hypertension"},{"issue":"7","key":"17305_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11936-015-0394-x","volume":"17","author":"WS Aronow","year":"2015","unstructured":"Aronow, W. S. Blood pressure goals and targets in the elderly. Curr. Treat. Options Cardiovasc. Med. 17 (7), 394 (2015).","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"issue":"22","key":"17305_CR4","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"SR Group","year":"2015","unstructured":"Group, S. R. et al. A randomized trial of intensive versus standard Blood-Pressure control. N. Engl. J. Med. 373 (22), 2103\u20132116 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"133","key":"17305_CR5","first-page":"1","volume":"2013","author":"T Nwankwo","year":"2013","unstructured":"Nwankwo, T., Yoon, S. S., Burt, V. & Gu, Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011\u20132012. NCHS data brief. 2013(133), 1\u20138 (2013).","journal-title":"NCHS data brief."},{"issue":"2","key":"17305_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/01.HYP.0000202568.01167.B6","volume":"47","author":"LJ Appel","year":"2006","unstructured":"Appel, L. J. et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American heart association. Hypertension 47 (2), 296\u2013308 (2006).","journal-title":"Hypertension"},{"issue":"2","key":"17305_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jada.2007.10.040","volume":"108","author":"JF Swain","year":"2008","unstructured":"Swain, J. F., McCarron, P. B., Hamilton, E. F., Sacks, F. M. & Appel, L. J. Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (OmniHeart): options for a heart-healthy diet. J. Am. Diet. Assoc. 108 (2), 257\u2013265 (2008).","journal-title":"J. Am. Diet. Assoc."},{"key":"17305_CR8","unstructured":"Liu, Y., Ma, W., Zhang, P., He, S. & Huang, D. Effect of Resveratrol on blood pressure: A meta-analysis of randomized controlled trials. Clin. Nutr. (2014)."},{"issue":"6","key":"17305_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/HYPERTENSIONAHA.113.02094","volume":"62","author":"D Rodriguez-Leyva","year":"2013","unstructured":"Rodriguez-Leyva, D. et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 62 (6), 1081\u20131089 (2013).","journal-title":"Hypertension"},{"issue":"3","key":"17305_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/10641963.2015.1089882","volume":"38","author":"X Li","year":"2016","unstructured":"Li, X. et al. Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production. Clin. Exp. Hypertens. 38 (3), 287\u2013293 (2016).","journal-title":"Clin. Exp. Hypertens."},{"issue":"1\u20133","key":"17305_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejphar.2011.05.026","volume":"667","author":"SR Bhatt","year":"2011","unstructured":"Bhatt, S. R., Lokhandwala, M. F. & Banday, A. A. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur. J. Pharmacol. 667 (1\u20133), 258\u2013264 (2011).","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"17305_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.bbadis.2013.05.018","volume":"1832","author":"VW Dolinsky","year":"2013","unstructured":"Dolinsky, V. W. et al. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim. Biophys. Acta. 1832 (10), 1723\u20131733 (2013).","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"17305_CR13","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/j.2042-7158.2010.01197.x","volume":"62","author":"HZ Toklu","year":"2010","unstructured":"Toklu, H. Z. et al. Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. J. Pharm. Pharmacol. 62 (12), 1784\u20131793 (2010).","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"17305_CR14","first-page":"1049","volume":"32","author":"Z Liu","year":"2005","unstructured":"Liu, Z. et al. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin. Exp. Pharmacol. Physiol. 32 (12), 1049\u20131054 (2005).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"17305_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.lfs.2013.12.011","volume":"95","author":"P Raj","year":"2014","unstructured":"Raj, P. et al. Potential of Resveratrol in the treatment of heart failure. Life Sci. 95 (2), 63\u201371 (2014).","journal-title":"Life Sci."},{"issue":"10","key":"17305_CR16","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/hr.2013.55","volume":"36","author":"SJ Thandapilly","year":"2013","unstructured":"Thandapilly, S. J. et al. Reduced hemodynamic load aids low-dose Resveratrol in reversing cardiovascular defects in hypertensive rats. Hypertens. Res. 36 (10), 866\u2013872 (2013).","journal-title":"Hypertens. Res."},{"issue":"3","key":"17305_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","volume":"54","author":"A Csiszar","year":"2009","unstructured":"Csiszar, A. et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 54 (3), 668\u2013675 (2009).","journal-title":"Hypertension"},{"issue":"19\u201320","key":"17305_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.lfs.2012.03.008","volume":"90","author":"C Chun","year":"2012","unstructured":"Chun, C. et al. Resveratrol downregulates acute pulmonary thromboembolism-induced pulmonary artery hypertension via p38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 signaling in rats. Life Sci. 90 (19\u201320), 721\u2013727 (2012).","journal-title":"Life Sci."},{"issue":"5","key":"17305_CR19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1161\/HYPERTENSIONAHA.115.06793","volume":"67","author":"AS Care","year":"2016","unstructured":"Care, A. S. et al. Perinatal Resveratrol supplementation to spontaneously hypertensive rat dams mitigates the development of hypertension in adult offspring. Hypertension 67 (5), 1038\u20131044 (2016).","journal-title":"Hypertension"},{"issue":"1","key":"17305_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2014.04.018","volume":"20","author":"JA Mattison","year":"2014","unstructured":"Mattison, J. A. et al. Resveratrol prevents high fat\/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates. Cell. Metab. 20 (1), 183\u2013190 (2014).","journal-title":"Cell. Metab."},{"issue":"1","key":"17305_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3892\/etm.2016.3958","volume":"13","author":"M Theodotou","year":"2017","unstructured":"Theodotou, M. et al. The effect of Resveratrol on hypertension: A clinical trial. Exp. Ther. Med. 13 (1), 295\u2013301 (2017).","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"17305_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13063-016-1426-x","volume":"17","author":"A Movahed","year":"2016","unstructured":"Movahed, A. et al. The efficacy of Resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial. Trials 17 (1), 296 (2016).","journal-title":"Trials"},{"issue":"28","key":"17305_CR23","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia, G. et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur. Heart J. 34 (28), 2159\u20132219 (2013).","journal-title":"Eur. Heart J."},{"issue":"1","key":"17305_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/ajcn.115.117440","volume":"103","author":"SS Thazhath","year":"2016","unstructured":"Thazhath, S. S. et al. Administration of Resveratrol for 5 Wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am. J. Clin. Nutr. 103 (1), 66\u201370 (2016).","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"17305_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","volume":"14","author":"S Timmers","year":"2011","unstructured":"Timmers, S. et al. Calorie Restriction-like effects of 30 days of Resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabol. 14 (5), 612\u2013622 (2011).","journal-title":"Cell Metabol."},{"issue":"10","key":"17305_CR26","doi-asserted-by":"publisher","first-page":"16102","DOI":"10.3390\/molecules191016102","volume":"19","author":"N Xia","year":"2014","unstructured":"Xia, N., F\u00f6rstermann, U. & Li, H. Resveratrol and endothelial nitric oxide. Molecules 19 (10), 16102\u201316121 (2014).","journal-title":"Molecules"},{"issue":"1","key":"17305_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.110.168724","volume":"335","author":"N Xia","year":"2010","unstructured":"Xia, N. et al. Resveratrol reverses endothelial Nitric-Oxide synthase uncoupling in Apolipoprotein E knockout mice. J. Pharmacol. Exp. Ther. 335 (1), 149 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"17305_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11906-012-0320-5","volume":"15","author":"R Thoonen","year":"2013","unstructured":"Thoonen, R., Sips, P. Y., Bloch, K. D. & Buys, E. S. Pathophysiology of hypertension in the absence of nitric oxide\/cyclic GMP signaling. Curr. Hypertens. Rep. 15 (1), 47\u201358 (2013).","journal-title":"Curr. Hypertens. Rep."},{"issue":"6","key":"17305_CR29","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/01.CIR.91.6.1732","volume":"91","author":"JA Panza","year":"1995","unstructured":"Panza, J. A., Garc\u00eda, C. E., Kilcoyne, C. M., Quyyumi, A. A. & Cannon, R. O. Impaired Endothelium-Dependent vasodilation in patients with essential hypertension. Circulation 91 (6), 1732\u20131738 (1995).","journal-title":"Circulation"},{"issue":"12 Suppl 4","key":"17305_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1524-6175.2006.06032.x","volume":"8","author":"M Hermann","year":"2006","unstructured":"Hermann, M., Flammer, A. & L\u00fcscher, T. F. Nitric oxide in hypertension. J. Clin. Hypertens. (Greenwich). 8 (12 Suppl 4), 17\u201329 (2006).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"3","key":"17305_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/10641963.2017.1288741","volume":"40","author":"B Marques","year":"2018","unstructured":"Marques, B. et al. Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction. Clin. Exp. Hypertens. 40 (3), 218\u2013223 (2018).","journal-title":"Clin. Exp. Hypertens."},{"key":"17305_CR32","doi-asserted-by":"publisher","first-page":"851267","DOI":"10.1155\/2013\/851267","volume":"2013","author":"A Movahed","year":"2013","unstructured":"Movahed, A. et al. Antihyperglycemic effects of short term Resveratrol supplementation in type 2 diabetic patients. Evidence-based Complement. Altern. Medicine: eCAM. 2013, 851267 (2013).","journal-title":"Evidence-based Complement. Altern. Medicine: eCAM"},{"issue":"7","key":"17305_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.nutres.2012.06.003","volume":"32","author":"JK Bhatt","year":"2012","unstructured":"Bhatt, J. K., Thomas, S. & Nanjan, M. J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res. 32 (7), 537\u2013541 (2012).","journal-title":"Nutr. Res."},{"key":"17305_CR34","doi-asserted-by":"publisher","first-page":"9734738","DOI":"10.1155\/2022\/9734738","volume":"2022","author":"W Gu","year":"2022","unstructured":"Gu, W., Geng, J., Zhao, H., Li, X. & Song, G. Effects of Resveratrol on metabolic indicators in patients with type 2 diabetes: A systematic review and Meta-Analysis. Int. J. Clin. Pract. 2022, 9734738 (2022).","journal-title":"Int. J. Clin. Pract."},{"issue":"10","key":"17305_CR35","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1080\/10408398.2017.1422480","volume":"59","author":"F Fogacci","year":"2019","unstructured":"Fogacci, F. et al. Effect of Resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. Crit. Rev. Food Sci. Nutr. 59 (10), 1605\u20131618 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"17305_CR36","doi-asserted-by":"crossref","unstructured":"Movahed, A. et al. Efficacy and safety of resveratrol in type 1 diabetes patients: a two-month preliminary exploratory trial. Nutrients 12(1) (2020).","DOI":"10.3390\/nu12010161"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17305-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T23:00:27Z","timestamp":1757458827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17305-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17305"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17305-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the regional research ethics committee of BPUMS (approval NO: B-93-16-4). The trial has been registered with the Iranian Registry of Clinical Trials NO: IRCT201407078129N7.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"31297"}}